Clinical trial
Phase IIa L-serine Trial for eAD
NCT03062449
Study timeline
Study start (actual)2017-03-01Date precision: day
Registry last updated2024-07-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer Diseaseunresolved
Interventions
L-SerineDRUG · verified · RxNorm: serine
Placebo GummyOTHER
Sponsors & collaborators
Aleksandra Starklead sponsor
Brain Chemistry Labscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03062449 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.